CYTOCHROME P450 AND XENOBIOTIC RECEPTOR HUMANIZED MICE
- 1 February 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 46 (1) , 41-64
Abstract
▪ Abstract Most xenobiotics that enter the body are subjected to metabolism that functions primarily to facilitate their elimination. Metabolism of certain xenobiotics can also result in the production of electrophilic derivatives that can cause cell toxicity and transformation. Many xenobiotics can also activate receptors that in turn induce the expression of genes encoding xenobiotic-metabolizing enzymes and xenobiotic transporters. However, there are marked species differences in the way mammals respond to xenobiotics, which are due in large part to molecular differences in receptors and xenobiotic-metabolizing enzymes. This presents a problem in extrapolating data obtained with rodent model systems to humans. There are also polymorphisms in xenobiotic-metabolizing enzymes that can impact drug therapy and cancer susceptibility. In an effort to generate more reliable in vivo systems to study and predict human response to xenobiotics, humanized mice are under development.Keywords
This publication has 140 references indexed in Scilit:
- THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITYDrug Metabolism and Disposition, 2005
- A TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEDrug Metabolism and Disposition, 2003
- Role of Gene Knockout and Transgenic Mice in the Study of Xenobiotic MetabolismDrug Metabolism Reviews, 2003
- The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesisMolecular and Cellular Endocrinology, 2002
- A Transgenic Mouse Expressing Human CYP4B1 in the LiverBiochemical and Biophysical Research Communications, 2001
- Expression of the Human Cholesterol 7α-Hydroxylase Gene in Transgenic MiceBiochemical and Biophysical Research Communications, 1999
- Antidepressant Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995
- Evidence That Cytochrome-P450 2E1 Is Involved in the (ω-1)-Hydroxylation of Lauric Acid in Rat Liver MicrosomesBiochemical and Biophysical Research Communications, 1994
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- MPTP, the neurotoxin inducing parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylationBiochemical and Biophysical Research Communications, 1987